In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Jurassic couture: Partnership looks to use T-Rex DNA to create dino leather handbags
In the Netherlands, a consortium of companies is looking to grow material similar to that of T-Rex skin to create a truly unique leather...
Chick-fil-A’s lemon waste eyed for bioplastics
In California, waste from Chick-fil-A’s lemon juice supplier could one day be used to produce bioplastics.
Bay Center Foods, which provides all of the...
Greek Startup Coffeeco Raises 715K Euros
In Greece, Coffeeco Upgrade SA, a company converting coffee waste into products like makeup and bioplastics, has raised €715,000 in the first close of...